A Prospective Open-Label Clinical Trial of Efficacy of the Every Week Administration of Adalimumab in the Treatment of Hidradenitis Suppurativa

Category Primary study
JournalJOURNAL OF DRUGS IN DERMATOLOGY
Year 2012
This article has no abstract
Epistemonikos ID: 105dc4b3ff39711a74528645cf4094645c107741
First added on: Nov 18, 2025